These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 17178888

  • 1. Tumor-suppressive effects of MBP-1 in non-small cell lung cancer cells.
    Ghosh AK, Steele R, Ryerse J, Ray RB.
    Cancer Res; 2006 Dec 15; 66(24):11907-12. PubMed ID: 17178888
    [Abstract] [Full Text] [Related]

  • 2. Carboxyl-terminal repressor domain of MBP-1 is sufficient for regression of prostate tumor growth in nude mice.
    Ghosh AK, Steele R, Ray RB.
    Cancer Res; 2005 Feb 01; 65(3):718-21. PubMed ID: 15705866
    [Abstract] [Full Text] [Related]

  • 3. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
    Katiyar SK, Meeran SM, Katiyar N, Akhtar S.
    Mol Carcinog; 2009 Jan 01; 48(1):24-37. PubMed ID: 18459128
    [Abstract] [Full Text] [Related]

  • 4. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ, Kong MJ, Ma ZY, Qian JF, Fan JQ, Xu XH.
    Zhonghua Yi Xue Za Zhi; 2007 Jun 05; 87(21):1506-9. PubMed ID: 17785094
    [Abstract] [Full Text] [Related]

  • 5. Gene therapy with secretory leukoprotease inhibitor promoter-controlled replication-competent adenovirus for non-small cell lung cancer.
    Maemondo M, Saijo Y, Narumi K, Kikuchi T, Usui K, Tazawa R, Matsumoto K, Nakamura T, Sasaki K, Takahashi M, Niitsu Y, Nukiwa T.
    Cancer Res; 2004 Jul 01; 64(13):4611-20. PubMed ID: 15231673
    [Abstract] [Full Text] [Related]

  • 6. Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude mice.
    Zhang YA, Nemunaitis J, Scanlon KJ, Tong AW.
    Gene Ther; 2000 Dec 01; 7(23):2041-50. PubMed ID: 11175317
    [Abstract] [Full Text] [Related]

  • 7. [Gene therapy with tumor suppressor gene p53 and(or) p16 on the nude mice models of NSCLC in vivo].
    Wu W, Zhang X, Qi X.
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jul 01; 23(7):403-5. PubMed ID: 11778504
    [Abstract] [Full Text] [Related]

  • 8. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
    Zhang W, Chen Y, Wei H, Zheng C, Sun R, Zhang J, Tian Z.
    Clin Cancer Res; 2008 Oct 15; 14(20):6432-9. PubMed ID: 18927282
    [Abstract] [Full Text] [Related]

  • 9. Interference with netrin-1 and tumor cell death in non-small cell lung cancer.
    Delloye-Bourgeois C, Brambilla E, Coissieux MM, Guenebeaud C, Pedeux R, Firlej V, Cabon F, Brambilla C, Mehlen P, Bernet A.
    J Natl Cancer Inst; 2009 Feb 18; 101(4):237-47. PubMed ID: 19211441
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of tumor cell growth by p21WAF1 adenoviral gene transfer in lung cancer.
    Joshi US, Chen YQ, Kalemkerian GP, Adil MR, Kraut M, Sarkar FH.
    Cancer Gene Ther; 1998 Feb 18; 5(3):183-91. PubMed ID: 9622102
    [Abstract] [Full Text] [Related]

  • 11. The effect of thalidomide on non-small cell lung cancer (NSCLC) cell lines: possible involvement in the PPARgamma pathway.
    DeCicco KL, Tanaka T, Andreola F, De Luca LM.
    Carcinogenesis; 2004 Oct 18; 25(10):1805-12. PubMed ID: 15205358
    [Abstract] [Full Text] [Related]

  • 12. [Therapeutic effects of recombinant mutant human tumor necrosis factor-related apoptosis-inducing ligand on non-small lung cell cancer: an experimental with rats].
    Tang YM, Yang SF, Zhu B, Cui JS.
    Zhonghua Yi Xue Za Zhi; 2005 Aug 03; 85(29):2021-5. PubMed ID: 16313792
    [Abstract] [Full Text] [Related]

  • 13. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
    Li YY, Chang JW, Chou WC, Liaw CC, Wang HM, Huang JS, Wang CH, Yeh KY.
    Lung Cancer; 2008 Feb 03; 59(2):180-91. PubMed ID: 17900752
    [Abstract] [Full Text] [Related]

  • 14. Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo.
    Ito I, Ji L, Tanaka F, Saito Y, Gopalan B, Branch CD, Xu K, Atkinson EN, Bekele BN, Stephens LC, Minna JD, Roth JA, Ramesh R.
    Cancer Gene Ther; 2004 Nov 03; 11(11):733-9. PubMed ID: 15486560
    [Abstract] [Full Text] [Related]

  • 15. Re-expression of TSLC1 in a non-small-cell lung cancer cell line induces apoptosis and inhibits tumor growth.
    Mao X, Seidlitz E, Truant R, Hitt M, Ghosh HP.
    Oncogene; 2004 Jul 22; 23(33):5632-42. PubMed ID: 15184878
    [Abstract] [Full Text] [Related]

  • 16. Enhanced therapeutic efficacy of oncolytic herpes vector G207 against human non-small cell lung cancer--expression of an RNA-binding protein, Musashi1, as a marker for the tailored gene therapy.
    Kanai R, Eguchi K, Takahashi M, Goldman S, Okano H, Kawase T, Yazaki T.
    J Gene Med; 2006 Nov 22; 8(11):1329-40. PubMed ID: 16955534
    [Abstract] [Full Text] [Related]

  • 17. Insulin-like growth factor binding protein-6 activates programmed cell death in non-small cell lung cancer cells.
    Sueoka N, Lee HY, Wiehle S, Cristiano RJ, Fang B, Ji L, Roth JA, Hong WK, Cohen P, Kurie JM.
    Oncogene; 2000 Sep 07; 19(38):4432-6. PubMed ID: 10980619
    [Abstract] [Full Text] [Related]

  • 18. Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice.
    Onn A, Isobe T, Itasaka S, Wu W, O'Reilly MS, Ki Hong W, Fidler IJ, Herbst RS.
    Clin Cancer Res; 2003 Nov 15; 9(15):5532-9. PubMed ID: 14654533
    [Abstract] [Full Text] [Related]

  • 19. Novel 2-step synthetic indole compound 1,1,3-tri(3-indolyl)cyclohexane inhibits cancer cell growth in lung cancer cells and xenograft models.
    Lee CH, Yao CF, Huang SM, Ko S, Tan YH, Lee-Chen GJ, Wang YC.
    Cancer; 2008 Aug 15; 113(4):815-25. PubMed ID: 18618576
    [Abstract] [Full Text] [Related]

  • 20. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
    Song Y, Shen K, Yu JR.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 06; 87(41):2919-24. PubMed ID: 18261307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.